Ben Anderson, Ph.D., gives The Cooper Union Albert Nerken School of Engineering 2022 The Theodore Eng’39, Mary, and Sara Kraut Endowed Lecture on the the path of a drug candidate from discovery to a commercial product.

Register

Ben Anderson, Ph.D., is vice president, global product leader in the Oncology Business Unit at Eli Lilly and Company. He is responsible for the global development and registration of several late-stage assets in the Lilly oncology portfolio. Prior to joining the Oncology Business Unit, Anderson was senior director of drug development at Eli Lilly Japan K.K. He served as co-chair of the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable and as a member of the National Academy of Science’s Board on chemical sciences and technology. Anderson received a Ph.D. in chemistry from the University of Chicago and was a National Institutes of Health postdoctoral fellow at Harvard University.

Attendees are required to show proof of COVID-19 vaccination and booster and must wear a CDC-recommended mask (disposable surgical, KN95, KF94, or N95) while indoors. Cloth masks alone are not permitted but may be worn as a second layer over a disposable surgical mask.